关注
Mark Lambie
Mark Lambie
在 keele.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
AS Levey, KU Eckardt, NM Dorman, SL Christiansen, EJ Hoorn, ...
Kidney international 97 (6), 1117-1129, 2020
6212020
Interleukin-6 signaling drives fibrosis in unresolved inflammation
CA Fielding, GW Jones, RM McLoughlin, L McLeod, VJ Hammond, ...
Immunity 40 (1), 40-50, 2014
3792014
Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival
M Lambie, J Chess, KL Donovan, YL Kim, JY Do, HB Lee, H Noh, ...
Journal of the American Society of Nephrology 24 (12), 2071-2080, 2013
2012013
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis—position paper for ISPD: 2017 update
EA Brown, J Bargman, W Van Biesen, MY Chang, FO Finkelstein, H Hurst, ...
Peritoneal Dialysis International 37 (4), 362-374, 2017
1792017
ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I–assessment and management of various cardiovascular risk factors
AYM Wang, KS Brimble, G Brunier, SG Holt, V Jha, DW Johnson, ...
Peritoneal Dialysis International 35 (4), 379-387, 2015
1702015
Establishing a core outcome set for peritoneal dialysis: report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) consensus workshop
KE Manera, DW Johnson, JC Craig, JI Shen, T Gutman, Y Cho, ...
American Journal of Kidney Diseases 75 (3), 404-412, 2020
1362020
The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis
J Perl, SJ Davies, M Lambie, RL Pisoni, K McCullough, DW Johnson, ...
Peritoneal Dialysis International 36 (3), 297-307, 2016
1352016
The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made
ML Lambie, B John, L Mushahar, C Huckvale, SJ Davies
Kidney international 78 (6), 611-618, 2010
1202010
Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis
M Tabinor, E Elphick, M Dudson, CS Kwok, M Lambie, SJ Davies
Scientific reports 8 (1), 4441, 2018
1192018
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ...
The Lancet 401 (10388), 1584-1594, 2023
992023
Determinants of peritoneal membrane function over time
SJ Davies, L Mushahar, Z Yu, M Lambie
Seminars in nephrology 31 (2), 172-182, 2011
992011
ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention
J Morelle, J Stachowska-Pietka, C Öberg, L Gadola, V La Milia, Z Yu, ...
Peritoneal Dialysis International 41 (4), 352-372, 2021
842021
ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients Part II–management of various cardiovascular complications
AYM Wang, KS Brimble, G Brunier, SG Holt, V Jha, DW Johnson, ...
Peritoneal Dialysis International 35 (4), 388-396, 2015
772015
Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study
MR Lambie, J Chess, AM Summers, PF Williams, N Topley, SJ Davies, ...
Nephrology Dialysis Transplantation 31 (3), 480-486, 2016
642016
UK Renal Registry
C Byrne, F Caskey, C Castledine, A Dawnay, D Ford, S Fraser, ...
Nephron 139 (1), 1-12, 2018
582018
Starting and withdrawing haemodialysis—associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and …
M Lambie, HC Rayner, JL Bragg-Gresham, RL Pisoni, VE Andreucci, ...
Nephrology Dialysis Transplantation 21 (10), 2814-2820, 2006
582006
AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis
J Morelle, C Marechal, Z Yu, H Debaix, T Corre, M Lambie, M Verduijn, ...
New England Journal of Medicine 385 (17), 1570-1580, 2021
532021
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ...
The Lancet 402 (10417), 2077-2090, 2023
502023
Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference
J Perl, EA Brown, CT Chan, C Couchoud, SJ Davies, R Kazancioğlu, ...
Kidney international 103 (5), 842-858, 2023
462023
Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis
M Lambie, M Bonomini, SJ Davies, D Accili, A Arduini, V Zammit
Trends in Endocrinology & Metabolism 32 (9), 721-730, 2021
442021
系统目前无法执行此操作,请稍后再试。
文章 1–20